Express Scripts today reminded its stockholders to vote “FOR” Express Scripts’ merger agreement with Cigna at the Express Scripts’ upcoming Special Meeting of Stockholders (the “Special Meeting”) that is scheduled to be held on August 24, 2018, at 9:00 a.m. CT. Express Scripts stockholders who have any questions or need assistance voting their shares should call (800) 690-6903.
Under the terms of the merger agreement, the transaction consideration consists of $48.75 in cash and 0.2434 shares of stock of the combined company per Express Scripts share. Upon closing of the transaction, Cigna stockholders will own approximately 64% of the combined company and Express Scripts stockholders will own approximately 36%.
Express Scripts’ Board of Directors unanimously recommends that Express Scripts’ stockholders vote “FOR” the adoption of the merger agreement with Cigna. In addition to the Board’s recommendation, Express Scripts notes that three leading independent proxy advisory firms Institutional Shareholder Services Inc., Glass, Lewis & Co., LLC and Egan-Jones Proxy Services have recommended that stockholders vote “FOR” the transaction.
The transaction is expected to be completed by December 31, 2018. It remains subject to the approval of Cigna and Express Scripts stockholders and the satisfaction of customary closing conditions, including applicable regulatory approvals.
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
Additional materials regarding the transaction, including more information on the strong strategic rationale and expected financial results, are available on Cigna and Express Scripts’ joint transaction website: https://www.advancinghealthcare.com/.
Date: August 20, 2018
Source: barchat